A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer
Ian Ganly, David Kirn, Susan G. Eckhardt, Gail I. Rodriguez, David S. Soutar, Randol Otto, Andrew G. Robertson, Oirhigh Park, Mark L. Gulley, Carla Heise, Daniel D. Von Hoff, Stanley B. Kaye
Profundice en los temas de investigación de 'A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer'. En conjunto forman una huella única.